PRINCETON, N.J. and CAMBRIDGE, Mass., June 1, 2025 /PRNewswire/ -- Taiho Oncology, Inc., and Cullinan Therapeutics, Inc., announced today the publication of positive results from the REZILIENT1 trial in the peer-reviewed Journal of Clinical Oncology (JCO). REZILIENT1 is a Phase 1/2,...
Read More Details
Finally We wish PressBee provided you with enough information of ( Taiho Oncology and Cullinan Therapeutics Announce Pivotal REZILIENT1 Phase 1/2 Data Published in the Journal of Clinical Oncology )
Also on site :
- 'Full House' Star, 43, Makes Rare Comment About Ashley Olsen
- '90s Rapper and Actor, 61, Makes Rare Red Carpet Appearance
- A Gaza-bound aid boat carrying Greta Thunberg and other activists has been diverted to Israel